基于生境分析对肝细胞癌Ki-67表达的预测
Prediction of Ki-67 Expression in Hepatocellular Carcinoma Based on Habitat Analysis
DOI: 10.12677/acm.2026.1641772, PDF,   
作者: 赵 敏*, 王 刚#:青岛大学附属医院放射科,山东 青岛
关键词: 肝细胞癌生境分析磁共振成像Hepatocellular Carcinoma Habitat Analysis Magnetic Resonance Imaging
摘要: 目的:构建一种基于钆塞酸二钠(Gd-EOB-DTPA)增强MRI的生境分析模型,用于术前预测肝细胞癌术前的Ki-67表达。方法:对来自两个医疗机构的433例经病理确诊的HCC患者进行回顾性分析。根据术后免疫组织化学检测的Ki-67表达水平,将患者分为Ki-67高表达组(n = 320)和低表达组(n = 113),并进一步按时间顺序划分为训练集(n = 349)和测试集(n = 84)。采用最小绝对收缩和选择算子(LASSO)回归分析筛选最优预测因子,建立基于磁共振成像的生境成像模型。使用受试者工作特征曲线下面积(AUC)、准确度、敏感度等评估性能。结果:一共提取了3290个特征并将肿瘤内部划分成2个区域,经特征降维后保留61个特征。在训练集和测试集中,生境分析模型的AUC值分别为0.836和0.814。结论:基于Gd-EOB-DTPA增强MRI的生境分析模型可作为术前无创预测Ki-67表达状态的有效方法。
Abstract: Objectives: Construction of a habitat analysis model based on Gd-EOB-DTPA-enhanced MRI for preoperative prediction of Ki-67 expression in hepatocellular carcinoma. Methods: A retrospective analysis was conducted on 433 patients with pathologically confirmed hepatocellular carcinoma (HCC) from two medical institutions. Based on the Ki-67 expression level detected by postoperative immunohistochemistry, patients were divided into a high Ki-67 expression group (n = 320) and a low expression group (n = 113), and were further chronologically divided into a training set (n = 349) and a test set (n = 84). The least absolute shrinkage and selection operator (LASSO) regression analysis was used to select optimal predictors for establishing a habitat imaging model based on magnetic resonance imaging. The performance of the model was evaluated using the area under the receiver operating characteristic curve (AUC), accuracy, and sensitivity. Results: A total of 3290 features were extracted, and the tumor was divided into two subregions. After feature dimensionality reduction, 61 features were retained. The habitat analysis model achieved AUC values of 0.836 and 0.814 in the training set and the test set, respectively. Conclusion: The habitat analysis model based on Gd-EOB-DTPA-enhanced MRI can serve as an effective method for noninvasive preoperative prediction of Ki-67 expression status.
文章引用:赵敏, 王刚. 基于生境分析对肝细胞癌Ki-67表达的预测[J]. 临床医学进展, 2026, 16(4): 4996-5007. https://doi.org/10.12677/acm.2026.1641772

参考文献

[1] Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[2] Xie, D., Ren, Z., Zhou, J., Fan, J. and Gao, Q. (2020) 2019 Chinese Clinical Guidelines for the Management of Hepatocellular Carcinoma: Updates and Insights. Hepatobiliary Surgery and Nutrition, 9, 452-463. [Google Scholar] [CrossRef] [PubMed]
[3] Forner, A., Reig, M. and Bruix, J. (2018) Hepatocellular Carcinoma. The Lancet, 391, 1301-1314. [Google Scholar] [CrossRef] [PubMed]
[4] Harbeck, N., Rastogi, P., Martin, M., Tolaney, S.M., Shao, Z.M., Fasching, P.A., et al. (2021) Adjuvant Abemaciclib Combined with Endocrine Therapy for High-Risk Early Breast Cancer: Updated Efficacy and Ki-67 Analysis from the MonarchE Study. Annals of Oncology, 32, 1571-1581. [Google Scholar] [CrossRef] [PubMed]
[5] Li, Z., Li, F., Pan, C., He, Z., Pan, X., Zhu, Q., et al. (2021) Tumor Cell Proliferation (Ki-67) Expression and Its Prognostic Significance in Histological Subtypes of Lung Adenocarcinoma. Lung Cancer, 154, 69-75. [Google Scholar] [CrossRef] [PubMed]
[6] Ramos-Santillan, V., Oshi, M., Nelson, E., Endo, I. and Takabe, K. (2024) High Ki67 Gene Expression Is Associated with Aggressive Phenotype in Hepatocellular Carcinoma. World Journal of Oncology, 15, 257-267. [Google Scholar] [CrossRef] [PubMed]
[7] Zhang, X., Wu, Z., Peng, Y., Li, D., Jiang, Y., Pan, F., et al. (2021) Correlationship between Ki67, VEGF, and P53 and Hepatocellular Carcinoma Recurrence in Liver Transplant Patients. BioMed Research International, 2021, Article ID: 6651397. [Google Scholar] [CrossRef] [PubMed]
[8] Nardone, V., Reginelli, A., Rubini, D., Gagliardi, F., Del Tufo, S., Belfiore, M.P., et al. (2024) Delta Radiomics: An Updated Systematic Review. La radiologia medica, 129, 1197-1214. [Google Scholar] [CrossRef] [PubMed]
[9] Ye, Z., Jiang, H., Chen, J., Liu, X., Wei, Y., Xia, C., et al. (2019) Texture Analysis on Gadoxetic Acid Enhanced-MRI for Predicting Ki-67 Status in Hepatocellular Carcinoma: A Prospective Study. Chinese Journal of Cancer Research, 31, 806-817. [Google Scholar] [CrossRef] [PubMed]
[10] Fan, Y., Yu, Y., Wang, X., Hu, M. and Hu, C. (2021) Radiomic Analysis of Gd-EOB-DTPA-Enhanced MRI Predicts Ki-67 Expression in Hepatocellular Carcinoma. BMC Medical Imaging, 21, Article No. 100. [Google Scholar] [CrossRef] [PubMed]
[11] Cai, C., Wang, L., Tao, L., Zhu, H., Ren, Y., Li, D., et al. (2025) Imaging‐Based Prediction of Ki‐67 Expression in Hepatocellular Carcinoma: A Retrospective Study. Cancer Medicine, 14, e70562. [Google Scholar] [CrossRef] [PubMed]
[12] Zhao, Y., Xie, S., Wang, J., Zhang, Y., Li, W., Ye, Z., et al. (2023) Added Value of CE-CT Radiomics to Predict High Ki-67 Expression in Hepatocellular Carcinoma. BMC Medical Imaging, 23, Article No. 138. [Google Scholar] [CrossRef] [PubMed]
[13] Zhou, L., Chen, Y., Li, Y., Wu, C., Xue, C. and Wang, X. (2024) Diagnostic Value of Radiomics in Predicting Ki-67 and Cytokeratin 19 Expression in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Frontiers in Oncology, 13, Article 1323534. [Google Scholar] [CrossRef] [PubMed]
[14] Zhang, D., Zhang, X., Lu, W., Liao, J., Zhang, C., Tang, Q., et al. (2024) Predicting Ki-67 Expression in Hepatocellular Carcinoma: Nomogram Based on Clinical Factors and Contrast-Enhanced Ultrasound Radiomics Signatures. Abdominal Radiology, 49, 1419-1431. [Google Scholar] [CrossRef] [PubMed]
[15] Napel, S., Mu, W., Jardim‐Perassi, B.V., Aerts, H.J.W.L. and Gillies, R.J. (2018) Quantitative Imaging of Cancer in the Postgenomic Era: Radio(geno)mics, Deep Learning, and Habitats. Cancer, 124, 4633-4649. [Google Scholar] [CrossRef] [PubMed]
[16] Jardim-Perassi, B.V., Huang, S., Dominguez-Viqueira, W., Poleszczuk, J., Budzevich, M.M., Abdalah, M.A., et al. (2019) Multiparametric MRI and Coregistered Histology Identify Tumor Habitats in Breast Cancer Mouse Models. Cancer Research, 79, 3952-3964. [Google Scholar] [CrossRef] [PubMed]
[17] Wang, C., Wu, F., Wang, F., Chong, H., Sun, H., Huang, P., et al. (2025) The Association between Tumor Radiomic Analysis and Peritumor Habitat‐Derived Radiomic Analysis on Gadoxetate Disodium‐Enhanced MRI with Microvascular Invasion in Hepatocellular Carcinoma. Journal of Magnetic Resonance Imaging, 61, 1428-1439. [Google Scholar] [CrossRef] [PubMed]
[18] Tang, M., Zhou, Q., Huang, M., Sun, K., Wu, T., Li, X., et al. (2021) Nomogram Development and Validation to Predict Hepatocellular Carcinoma Tumor Behavior by Preoperative Gadoxetic Acid-Enhanced MRI. European Radiology, 31, 8615-8627. [Google Scholar] [CrossRef] [PubMed]
[19] Murakami, T., Sofue, K. and Hori, M. (2022) Diagnosis of Hepatocellular Carcinoma Using Gd-EOB-DTPA MR Imaging. Magnetic Resonance in Medical Sciences, 21, 168-181. [Google Scholar] [CrossRef] [PubMed]
[20] Yan, M., Zhang, X., Zhang, B., Geng, Z., Xie, C., Yang, W., et al. (2023) Deep Learning Nomogram Based on Gd-EOB-DTPA MRI for Predicting Early Recurrence in Hepatocellular Carcinoma after Hepatectomy. European Radiology, 33, 4949-4961. [Google Scholar] [CrossRef] [PubMed]
[21] Yang, F., Wan, Y., Xu, L., Wu, Y., Shen, X., Wang, J., et al. (2021) MRI-Radiomics Prediction for Cytokeratin 19-Positive Hepatocellular Carcinoma: A Multicenter Study. Frontiers in Oncology, 11, Article 672126. [Google Scholar] [CrossRef] [PubMed]
[22] Wu, H., Han, X., Wang, Z., Mo, L., Liu, W., Guo, Y., et al. (2020) Prediction of the Ki-67 Marker Index in Hepatocellular Carcinoma Based on CT Radiomics Features. Physics in Medicine & Biology, 65, Article ID: 235048. [Google Scholar] [CrossRef] [PubMed]
[23] Dong, Y., Zuo, D., Qiu, Y., Cao, J., Wang, H. and Wang, W. (2022) Prediction of Histological Grades and Ki-67 Expression of Hepatocellular Carcinoma Based on Sonazoid Contrast Enhanced Ultrasound Radiomics Signatures. Diagnostics, 12, Article 2175. [Google Scholar] [CrossRef] [PubMed]
[24] Qiu, G., Chen, J., Liao, W., Liu, Y., Wen, Z. and Zhao, Y. (2023) Gadoxetic Acid-Enhanced MRI Combined with T1 Mapping and Clinical Factors to Predict Ki-67 Expression of Hepatocellular Carcinoma. Frontiers in Oncology, 13, Article 1134646. [Google Scholar] [CrossRef] [PubMed]
[25] Liu, Z., Yang, S., Chen, X., Luo, C., Feng, J., Chen, H., et al. (2022) Nomogram Development and Validation to Predict Ki-67 Expression of Hepatocellular Carcinoma Derived from Gd-EOB-DTPA-Enhanced MRI Combined with T1 Mapping. Frontiers in Oncology, 12, Article 954445. [Google Scholar] [CrossRef] [PubMed]
[26] Li, H., Zhang, J., Liu, B., Zheng, Z. and Xu, Y. (2025) Histogram Analysis of Multiple Mathematical Diffusion-Weighted Imaging Models for Preoperative Prediction of Ki-67 Expression in Hepatocellular Carcinoma. Frontiers in Oncology, 15, Article 1531236. [Google Scholar] [CrossRef] [PubMed]
[27] Yan, Y., Lin, X.S., Ming, W.Z., Chuan, Z.Q., Hui, G., Juan, S.Y., et al. (2024) Radiomic Analysis Based on Gd-EOB-DTPA Enhanced MRI for the Preoperative Prediction of Ki-67 Expression in Hepatocellular Carcinoma. Academic Radiology, 31, 859-869. [Google Scholar] [CrossRef] [PubMed]
[28] Zhang, H.D., Li, X.M., Zhang, Y.H., et al. (2023) Evaluation of Preoperative Microvascular Invasion in Hepatocellular Carcinoma Through Multidimensional Parameter Combination Modeling Based on Gd-EOB-DTPA MRI. Journal of Clinical and Translational Hepatology, 11, 350-359.
[29] Zhang, Y., Yang, C., Qian, X., Dai, Y. and Zeng, M. (2024) Evaluate the Microvascular Invasion of Hepatocellular Carcinoma (≤5 cm) and Recurrence Free Survival with Gadoxetate Disodium‐Enhanced MRI‐Based Habitat Imaging. Journal of Magnetic Resonance Imaging, 60, 1664-1675. [Google Scholar] [CrossRef] [PubMed]
[30] Zhang, Y., Chen, J., Yang, C., Dai, Y. and Zeng, M. (2024) Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma Using Diffusion-Weighted Imaging-Based Habitat Imaging. European Radiology, 34, 3215-3225. [Google Scholar] [CrossRef] [PubMed]
[31] Chen, Y., Qin, X., Long, L., Zhang, L., Huang, Z., Jiang, Z., et al. (2020) Diagnostic Value of Gd‐EOB‐DTPA‐Enhanced MRI for the Expression of Ki67 and Microvascular Density in Hepatocellular Carcinoma. Journal of Magnetic Resonance Imaging, 51, 1755-1763. [Google Scholar] [CrossRef] [PubMed]
[32] Hu, X., Yang, Z., Liang, H., Ding, Y., Grimm, R., Fu, C., et al. (2017) Whole‐Tumor MRI Histogram Analyses of Hepatocellular Carcinoma: Correlations with Ki‐67 Labeling Index. Journal of Magnetic Resonance Imaging, 46, 383-392. [Google Scholar] [CrossRef] [PubMed]
[33] Li, Y., Chen, J., Weng, S., Sun, H., Yan, C., Xu, X., et al. (2019) Small Hepatocellular Carcinoma: Using MRI to Predict Histological Grade and Ki-67 Expression. Clinical Radiology, 74, 653.e1-653.e9. [Google Scholar] [CrossRef] [PubMed]